Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4766-4770, September 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glickman, L. T.
Right arrow Articles by Fleiszer, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glickman, L. T.
Right arrow Articles by Fleiszer, D. M.

Proliferative Characteristics of Colonic Crypt Cells in C57BL/6J and A/J Mice as Predictors of Subsequent Tumor Formation

Laurence T. Glickman, Samy Suissa and David M. Fleiszer1

Departments of Surgery [L. T. G., D. M. F.] and Epidemiology and Biostatistics [S. S.], The Montreal General Hospital and McGill University, Montreal, Quebec, Canada, H3G 1A4

It has been proposed that the number and extent of tumors formed after chronic exposure to dimethylhydrazine (DMH) can be predicted by the indigenous number and distribution of DNA-synthesizing cells in the murine colonic mucosa, and that this sensitivity to DMH is genetically determined. In order to test this hypothesis we studied two genetically distinct inbred strains of mice; the DMH-sensitive A/J (A) mouse, and the relatively DMH-resistant C57BL/6J (B) mouse before and after a single exposure to DMH. The untreated A strain had the longer crypt column [33.2 ± 0.8 (SD) cells versus 28.8 ± 0.9 cells], a higher absolute number of labeled cells per crypt column (4.4 ± 0.6 versus 2.6 ± 0.9), a greater labeling index (13.4 ± 1.6% versus 9.1 ± 2.9%), a wider proliferative compartment, and a greater number and percentage of labeled cells in the middle and upper thirds of the crypt than the untreated B strain. After acute exposure to DMH the A strain lost 14 ± 3% of their total body weight, while the B strain lost 0.5 ± 2% total body weight 48 h post-DMH. There was an initial loss of cryptal cells, a drop in the labeling index, and a subsequent increase and overshoot in the number of labeled cells and the labeling index. This pattern of cell loss and recovery over time was parallel in both strains, and thus cannot explain the differences in ultimate tumor formation after chronic exposure to the carcinogen. The data are consistent with the theory that the susceptibility to DMH carcinogenesis can be predicted by the indigenous proliferative characteristics of the murine colonic mucosa. The acute proliferative response to DMH in these strains is similar and parallel; thus ultimate tumor load may depend on long term effects such as the establishment of stable transmissible mutations.

1 To whom requests for reprints should be addressed, at The Montreal General Hospital, The University Surgical Clinic, 1650 Cedar Avenue, Room 971, Montreal, Quebec, Canada, H3G 1A4.

Received 5/ 6/85. Revised 2/25/86. Revised 2/24/87. Accepted 6/ 3/87.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
Q.-S. Wang, A. Walsh, J. S. Goldsby, A. Papanikolaou, A. B. Bolt, and D. W. Rosenberg
Preliminary analysis of azoxymethane-induced colon tumorigenesis in mouse aggregation chimeras
Carcinogenesis, April 1, 1999; 20(4): 691 - 697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.